Table 2.
Summary of collected data at each time point according to SPIRIT 2013 guidelines.
| Period week | Enrollment |
Allocation |
Treatment |
Follow-up |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Week −2 | Week 0 | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 8 | |
| Enrollment | |||||||||
| Eligibility screening | x | ||||||||
| Informed consent | x | ||||||||
| Allocation | x | ||||||||
| Baseline information | x | ||||||||
| Randomization | x | ||||||||
| Intervention | |||||||||
| CHM group | x | x | x | x | x | x | |||
| Control group | x | x | x | x | x | x | |||
| Assessment | |||||||||
| OM onset | x | x | x | x | x | x | x | ||
| Intensity of OM | x | x | x | x | x | x | x | ||
| Nutritional status | x | x | x | x | x | x | x | ||
| Quality of life | x | x | x | ||||||
| Safety monitoring | x | x | x | x | x | x | x | ||
| Adverse events (side effects and complications) | x | x | x | x | x | x | x | ||
CHM: Chinese herbal medicine, OM: oral mucositis, TCM: traditional Chinese medicine.